Gene Ontology (GO): The identifier "At5g07050" does not correspond to any validated Arabidopsis thaliana gene locus in TAIR (The Arabidopsis Information Resource) or UniProt.
Antibody Catalogs: No commercial vendors (e.g., PhytoAB, Thermo Fisher, Abcam) list antibodies targeting a protein encoded by "At5g07050" .
Structural Databases: Protein Data Bank (PDB) and EMDB lack entries associated with this identifier.
The closest valid locus is AT5G25550, encoding a leucine-rich repeat extensin-like protein 7, for which antibodies are commercially available .
Discrepancies in alphanumeric sequences (e.g., "At5g07050" vs. "AT5G25550") may indicate a transcription error or outdated nomenclature.
If pursuing research on this compound:
Verify Gene/Protein Identity: Cross-check identifiers with updated genomic databases (e.g., TAIR, NCBI).
Explore Homologs: Investigate antibodies targeting homologous proteins in related plant species.
Custom Antibody Development: Contact specialized providers (e.g., PhytoAB, Agrisera) for epitope-specific synthesis .
While "At5g07050 Antibody" remains uncharacterized, studies on Arabidopsis antibodies highlight methodological frameworks applicable to hypothetical inquiries:
Here’s a structured collection of FAQs tailored to academic researchers working with the At5g07050 antibody, incorporating methodological guidance and experimental insights:
Methodology:
Perform Western blot using protein extracts from wild-type and At5g07050 knockout lines. Expect a band at the predicted molecular weight (~55 kDa for WAT1-related proteins). Include a positive control (e.g., recombinant At5g07050 protein).
Use immunofluorescence in plant root sections with antibody pre-absorption against the immunogen peptide to confirm signal loss .
Validate cross-reactivity by testing homologs (e.g., Arabidopsis WAT1) via comparative ELISA .
Protocol:
| Application | Buffer | Dilution | Incubation Time |
|---|---|---|---|
| Western Blot | TBST + 5% BSA | 1:500 | 1 hour (RT) |
| Immunofluorescence | PBS + 0.1% Triton | 1:200 | Overnight (4°C) |
Troubleshooting:
Analysis framework:
Compare confocal microscopy (antibody-based) with transgenic GFP fusion constructs. Discrepancies may arise from epitope masking or overexpression artifacts.
Use cell fractionation (nuclear/cytoplasmic/membrane) followed by Western blot to validate compartment-specific signals .
Reference conflicting studies:
| Study | Localization | Method | Possible Bias |
|---|---|---|---|
| A | Plasma Membrane | Immunofluorescence | Fixation artifact |
| B | Vacuolar | GFP fusion | Overexpression |
Optimization:
Workflow:
Integrated approach:
| Sample | mRNA Level (FPKM) | Protein Level (ng/mL) |
|---|---|---|
| WT | 12.5 ± 1.2 | 8.3 ± 0.9 |
| Mutant | 0.9 ± 0.3 | 7.1 ± 1.1 |
Interpretation: Persistent protein in mutants suggests long half-life or cross-reactivity .